Cerebellum and Autism: Regional Specialization for Social and Executive Functions
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-35
SponsorAmerican University
About this trial
The goal of this study is to determine the impact of neuromodulation to the cerebellum on social and executive functions in neurotypical young adults and young adults with autism.
Eligibility criteria
Qualifiers
Aged 18-35
Able to provide written, informed consent
NIH Toolbox age-adjusted Cognitive Function Composite standard score ≥ 85
Native English speaker
Disqualifiers
Age <18 or >35
NIH Toolbox age-adjusted Cognitive Function Composite standard score < 85
Contraindications for MRI or neuromodulation with tDCS (e.g. metal in body, pacemaker or other implanted device, history of seizure, claustrophobia)
Current or prior history of neurological or neurodevelopmental condition or brain injury
Trial design
Treatments tested in this trial
- Transcranial direct current stimulation
Treatment groups
80 Participants
are divided into 2 treatment groupsSponsors and collaborators
American University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov